TD Cowen Highlights AstraZeneca's (AZN) 'Attractive Valuation'; Stock Named Europe Best Ideas
Tweet Send to a Friend
TD Cowen analyst Steve Scala reiterated a Buy rating and $95.00 price target on AstraZeneca (NASDAQ: AZN).The analyst commented: "Europe ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
